● About 32.5 million shares changed hands.
● Proteus can now identify 19 of the 20 amino acids.
● Recursion Pharmaceuticals climbed solidly on Friday as biotech stocks rallied, with no announcement from the company.
● ImmunityBio climbed on Friday, trading at about $10.60 by mid-morning as cancer-focused biotech stocks rallied.
● Illumina jumped on Friday, ranking among the S&P 500's stronger gainers, though no company announcement explained the move.
● Iovance Biotherapeutics jumped strongly on Friday as cancer-focused drug developers rallied, with no company news of its own.
● Johnson & Johnson gained on Friday, closing at $261.44 and finishing among the Dow's advancers, with no fresh company news.
● Merck had no company-specific announcement and was lifted by a wave of buying across drugmakers and biotech companies.
● Moderna rocketed on Friday, closing at $225.00, up $28.00, at the top of its day's range of $197.17 to $225.00.
● Moderna climbed $28.00 to $225.00 on Friday, taking the stock to its highest level since 2021, according to market data.